ClinicalTrials.gg
Sign In

Drug

Calderasib clinical trials

Also written MK-1084.

studies test it
10
open now
5
in phase 3
5
first study started
2024

Keep track of what changes. Save the calderasib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Calderasib
9

Development codes

MK-1084
10

Studies by the year they started

10 studies that test it; most in 2025 (5)

Studies that test calderasib, by start year
YearStudies
20243
20255
20262

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung
5
Colonic Neoplasms
1

Who runs them

Industry 10 · Other 0

Merck Sharp & Dohme LLC (10)

Often tested with

Tested in the same studies.

Cetuximab (1)

Studies

Open first, then newest update. How each study uses calderasib is read from its arms, and is right about nine times in ten.

Testing it · 10

Given in every arm · 7 — calderasib is usual care beside what is tested

Codes

What other systems call calderasib · ClinicalTrials.gg INT018612

  • UNII (FDA) YQF4ART47CCALDERASIBConfirmed FDA, Wikidata
  • Wikidata Q140528731calderasibConfirmed FDA, Wikidata
  • NCI Thesaurus C185288CalderasibOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.